| Literature DB >> 35706666 |
Jovica Branković1, Nevena Milivojević2, Vesna Milovanović3, Dušica Simijonović2, Zorica D Petrović1, Zoran Marković2, Dragana S Šeklić2, Marko N Živanović2, Milena D Vukić1, Vladimir P Petrović1.
Abstract
Cancer is still a relentless public health issue. Particularly, colorectal cancer is the third most prevalent cancer in men and the second in women. Moreover, cancer development and growth are associated with various cell disorders, such as oxidative stress and inflammation. The quest for efficient therapeutics is a challenging task, especially when it comes to achieving both cytotoxicity and selectivity. Herein, five series of phenolic N-acylhydrazones were synthesized and evaluated for their antioxidant potency, as well as their influence on HCT-116 and MRC-5 cells viability. Among 40 examined analogues, 20 of them expressed antioxidant activity against the DPPH radical. Furthermore, density functional theory was employed to estimate the antioxidant potency of the selected analogues from the thermodynamical aspect, as well as the preferable free-radical scavenging pathway. Cytotoxicity assay exposed enhanced selectivity of a number of analogues toward cancer cells. The structure-activity analysis revealed the impact of the type and position of the functional groups on both cell viability and selectivity toward cancer cells.Entities:
Keywords: antioxidant activity; cytotoxic activity; density functional theory; phenolic N-acylhydrazones; structure–activity relationship
Year: 2022 PMID: 35706666 PMCID: PMC9174720 DOI: 10.1098/rsos.211853
Source DB: PubMed Journal: R Soc Open Sci ISSN: 2054-5703 Impact factor: 3.653
Figure 1-based drugs.
Scheme 1Synthesis of the five series of Phes.
Electronic transitions responsible for experimental bands for compounds 5a–h.
| transition | transition | transition | transition | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HOMO | LUMO | 308.5 | HOMO | LUMO | 327.5 | HOMO | LUMO | 320 | HOMO | LUMO | 341 |
| HOMO-1 | LUMO | HOMO-3 | LUMO | 299.5 | HOMO-1 | LUMO+1 | 213 | HOMO-1 | LUMO | 310.5 | |
| HOMO-3 | LUMO | 213.5 | HOMO-1 | LUMO | HOMO-3 | LUMO | HOMO-2 | LUMO | 297.5 | ||
| HOMO | LUMO+2 | HOMO-3 | LUMO | 290 | HOMO | LUMO+2 | HOMO-6 | LUMO | 213 | ||
| HOMO-1 | LUMO+2 | HOMO | LUMO+1 | HOMO-2 | LUMO+2 | HOMO-5 | LUMO | ||||
| HOMO | LUMO+3 | HOMO-3 | LUMO+1 | 213.5 | HOMO-1 | LUMO+3 | HOMO-1 | LUMO+2 | |||
| HOMO-2 | LUMO+1 | HOMO | LUMO+2 | HOMO-1 | LUMO+6 | HOMO | LUMO+9 | ||||
| HOMO-1 | LUMO+3 | HOMO-1 | LUMO+2 | HOMO | LUMO+9 | HOMO-1 | LUMO+2 | ||||
| HOMO-3 | LUMO+1 | HOMO-1 | LUMO+3 | HOMO-2 | LUMO+3 | HOMO | LUMO+4 | ||||
| HOMO-2 | LUMO+2 | HOMO-3 | LUMO+2 | HOMO | LUMO+8 | HOMO-4 | LUMO+1 | ||||
| HOMO-2 | LUMO+3 | HOMO | LUMO+8 | HOMO-2 | LUMO+2 | ||||||
| HOMO | LUMO+6 | HOMO-2 | LUMO+3 | HOMO-3 | LUMO+2 | ||||||
| HOMO-1 | LUMO+5 | HOMO | LUMO+7 | HOMO-2 | LUMO+4 | ||||||
Experimental IC50 (μM) values for inactivation of DPPH free radical for compounds 1–5.
| IC50 | >100 | >100 | >100 | >100 | 31.4 ± 0.9 | 17.2 ± 1.1 | >100 | 2.93 ± 0.1 |
| SF | / | / | / | / | 0.4 | 0.7 | / | 4.3 |
| IC50 | >100 | >100 | >100 | >100 | 20.1 ± 0.9 | 6.5 ± 0.4 | >100 | 1.6 ± 0.0 |
| SF | / | / | / | / | 0.6 | 1.9 | / | 7.8 |
| IC50 | >100 | >100 | >100 | >100 | 28.4 ± 0.2 | 16.6 ± 0.2 | >100 | 2.5 ± 0.1 |
| SF | / | / | / | / | 0.4 | 0.8 | / | 5 |
| IC50 | >100 | >100 | >100 | >100 | 22.1 ± 1.1 | 6.3 ± 0.3 | >100 | 3.4 ± 0.1 |
| SF | / | / | / | / | 0.6 | 2 | / | 3.7 |
| IC50 | 1.3 ± 0.1 | 1.2 ± 0.1 | 2.9 ± 0.1 | 1.0 ± 0.1 | 1.9 ± 0.1 | 1.1 ± 0.1 | 0.9 ± 0.1 | 0.7 ± 0.1 |
| SF | 9.6 | 10.4 | 4.3 | 12.5 | 6.6 | 11.4 | 13.9 | 17.9 |
| IC50 | 1.7 ± 0.1 | 1.9 ± 0.1 | ||||||
| SF | 7.4 | 6.6 |
Calculated electronic properties of compounds 1a–h in methanol.
| compound | HOMO (eV) | LUMO (eV) | HOMO-LUMO gap (eV) | Δ | |
|---|---|---|---|---|---|
| methanol | |||||
| NH | −0.235 | −0.074 | 0.161 | 60.961 | |
| R5-OH (B) | −0.233 | −0.078 | 0.155 | 22.653 | |
| NH | 18.258 | ||||
| R7-OH (B) | −0.226 | −0.073 | 0.153 | −18.392 | |
| NH | 15.787 | ||||
| R5-OH (B) | −0.224 | −0.077 | 0.147 | −8.588 | |
| NH | 15.588 | ||||
| R7-OH (B) | −0.221 | −0.073 | 0.148 | −25.932 | |
| NH | 13.818 | ||||
| R7-OH (B) | −0.216 | −0.073 | 0.143 | −43.310 | |
| NH | 11.011 | ||||
| R5-OH (B) | −0.225 | −0.074 | 0.151 | 21.038 | |
| R7-OH (B) | −11.707 | ||||
| NH | 8.357 | ||||
| R6-OH (B) | −0.223 | −0.073 | 0.150 | −35.221 | |
| R7-OH (B) | −46.072 | ||||
| NH | 15.884 | ||||
Calculated electronic properties of compounds 5a–h in methanol.
| compound | HOMO (eV) | LUMO (eV) | HOMO-LUMO gap (eV) | Δ | |
|---|---|---|---|---|---|
| methanol | |||||
| R2-OH (A) | −0.233 | −0.076 | 0.157 | −21.600 | |
| R3-OH (A) | −47.419 | ||||
| R4-OH (A) | −24.7532 | ||||
| NH | 20.613 | ||||
| R2-OH (A) | −0.230 | −0.076 | 0.154 | −20.891 | |
| R3-OH (A) | −46.561 | ||||
| R4-OH (A) | −23.871 | ||||
| R5-OH (B) | 24.866 | ||||
| NH | 13.831 | ||||
| R2-OH (A) | −0.224 | −0.071 | 0.153 | −22.141 | |
| R3-OH (A) | −48.249 | ||||
| R4-OH (A) | −25.352 | ||||
| R7-OH (B) | −19.350 | ||||
| NH | 12.311 | ||||
| R2-OH (A) | −0.224 | −0.076 | 0.148 | −20.896 | |
| R3-OH (A) | −46.624 | ||||
| R4-OH (A) | −21.400 | ||||
| R5-OH (B) | −5.991 | ||||
| NH | 14.159 | ||||
| R2-OH (A) | −0.220 | −0.071 | 0.149 | −21.915 | |
| R3-OH (A) | −48.133 | ||||
| R4-OH (A) | −25.102 | ||||
| R7-OH (B) | −26.560 | ||||
| NH | 10.124 | ||||
| R2-OH (A) | −0.215 | −0.075 | 0.140 | −24.593 | |
| R3-OH (A) | -48.199 | ||||
| R4-OH (A) | −24.9081 | ||||
| R7-OH (B) | −43.8669 | ||||
| NH | 7.690 | ||||
| R2-OH (A) | −0.223 | −0.071 | 0.152 | −21.211 | |
| R3-OH (A) | −47.327 | ||||
| R4-OH (A) | −24.270 | ||||
| R5-OH (B) | 23.307 | ||||
| R7-OH (B) | −12.592 | ||||
| NH | 4.750 | ||||
| R2-OH (A) | −0.221 | −0.071 | 0.150 | −21.923 | |
| R3-OH (A) | −47.973 | ||||
| R4-OH (A) | −25.344 | ||||
| R6-OH (B) | −35.557 | ||||
| R7-OH (B) | −46.700 | ||||
| NH | 12.503 | ||||
Calculated thermodynamic parameters (kJ mol−1) of compounds 5a–h in methanol.
| HAT | SET-PT | SPLET | ||||
|---|---|---|---|---|---|---|
| BDE | IP | PDE | PA | ETE | ||
| methanol | ||||||
| R2-OH (A) | 331 | 506 | −14 | 123 | 370 | |
| R3-OH (A) | 305 | −40 | 101 | 366 | ||
| R4-OH (A) | 328 | −17 | 122 | 367 | ||
| NH | 373 | 28 | 162 | 373 | ||
| R2-OH (A) | 332 | 498 | −5 | 122 | 372 | |
| R3-OH (A) | 306 | −31 | 99 | 369 | ||
| R4-OH (A) | 329 | −8 | 121 | 370 | ||
| R5-OH (B) | 377 | 40 | 176 | 363 | ||
| NH | 366 | 29 | 145 | 383 | ||
| R2-OH (A) | 330 | 478 | 14 | 123 | 368 | |
| R3-OH (A) | 304 | −12 | 102 | 364 | ||
| R4-OH (A) | 327 | 11 | 123 | 366 | ||
| R7-OH (B) | 333 | 17 | 137 | 358 | ||
| NH | 365 | 49 | 166 | 361 | ||
| R2-OH (A) | 332 | 480 | 13 | 124 | 369 | |
| R3-OH (A) | 306 | −12 | 102 | 366 | ||
| R4-OH (A) | 331 | 13 | 123 | 369 | ||
| R5-OH (B) | 346 | 28 | 161 | 347 | ||
| NH | 367 | 48 | 145 | 383 | ||
| R2-OH (A) | 331 | 468 | 24 | 124 | 368 | |
| R3-OH (A) | 304 | −3 | 102 | 364 | ||
| R4-OH (A) | 327 | 21 | 123 | 366 | ||
| R7-OH (B) | 326 | 19 | 146 | 342 | ||
| NH | 363 | 56 | 163 | 361 | ||
| R2-OH (A) | 328 | 456 | 33 | 123 | 366 | |
| R3-OH (A) | 304 | 10 | 102 | 364 | ||
| R4-OH (A) | 328 | 33 | 122 | 367 | ||
| R7-OH (B) | 309 | 14 | 144 | 326 | ||
| NH | 360 | 65 | 165 | 357 | ||
| R2-OH (A) | 331 | 478 | 15 | 122 | 370 | |
| R3-OH (A) | 305 | −11 | 100 | 367 | ||
| R4-OH (A) | 328 | 12 | 121 | 369 | ||
| R5-OH (B) | 376 | 59 | 173 | 365 | ||
| R7-OH (B) | 340 | 23 | 135 | 366 | ||
| NH | 357 | 41 | 148 | 371 | ||
| R2-OH (A) | 331 | 474 | 18 | 123 | 369 | |
| R3-OH (A) | 304 | −8 | 102 | 364 | ||
| R4-OH (A) | 327 | 15 | 123 | 366 | ||
| R6-OH (B) | 317 | 5 | 128 | 351 | ||
| R7-OH (B) | 306 | −6 | 118 | 350 | ||
| NH | 365 | 53 | 165 | 362 | ||
Calculated reaction enthalpies (kJ mol−1) for the reactions of compound 5h with selected radials in methanol.
| 5 h | IC50 (µM) = 0.7 ± 0.1 | |||||
|---|---|---|---|---|---|---|
| HAT | SET-PT | SPLET | ||||
| radical | position | Δ | Δ | Δ | Δ | Δ |
| .OCH3 | R2-OH (A) | −89 | 130 | −219 | −114 | 25 |
| R3-OH (A) | −115 | −245 | −136 | 21 | ||
| R4-OH (A) | −92 | −222 | −115 | 23 | ||
| R6-OH (B) | −102 | −233 | −110 | 7 | ||
| R7-OH (B) | −113 | −244 | −120 | 6 | ||
| NH | −54 | −185 | −73 | 19 | ||
| .OC(CH3)3 | R2-OH (A) | −97 | 130 | −227 | −122 | 25 |
| R3-OH (A) | −123 | −253 | −144 | 21 | ||
| R4-OH (A) | −100 | −230 | −123 | 23 | ||
| R6-OH (B) | −110 | −241 | −117 | 7 | ||
| R7-OH (B) | −121 | −252 | −128 | 6 | ||
| NH | −62 | −192 | −81 | 18 | ||
| .OH | R2-OH (A) | −158 | 57 | −216 | −110 | −48 |
| R3-OH (A) | −185 | −242 | −132 | −52 | ||
| R4-OH (A) | −162 | −219 | −111 | −51 | ||
| R6-OH (B) | −172 | −229 | −106 | −66 | ||
| R7-OH (B) | −183 | −240 | −116 | −67 | ||
| NH | −124 | −181 | −69 | −55 | ||
| .OOH | R2-OH (A) | −21 | 154 | −175 | −70 | 49 |
| R3-OH (A) | −47 | −201 | −91 | 45 | ||
| R4-OH (A) | −24 | −178 | −71 | 47 | ||
| R6-OH (B) | −34 | −188 | −65 | 31 | ||
| R7-OH (B) | −45 | −200 | −75 | 30 | ||
| NH | 14 | −140 | −28 | 42 | ||
| .OOCH3 | R2-OH (A) | −12 | 164 | −176 | −71 | 59 |
| R3-OH (A) | −38 | −202 | −93 | 55 | ||
| R4-OH (A) | −15 | −179 | −72 | 56 | ||
| R6-OH (B) | −26 | −190 | −66 | 41 | ||
| R7-OH (B) | −37 | −201 | −77 | 40 | ||
| NH | 23 | −141 | −30 | 52 | ||
| .OO–CH = CH2 | R2-OH (A) | −13 | 135 | −147 | −42 | 30 |
| R3-OH (A) | −39 | −174 | −64 | 25 | ||
| R4-OH (A) | −16 | −151 | −43 | 27 | ||
| R6-OH (B) | −26 | −161 | −38 | 12 | ||
| R7-OH (B) | −38 | −172 | −48 | 11 | ||
| NH | 22 | −113 | −1 | 23 | ||
| DPPH | R2-OH (A) | 10 | 89 | −79 | 26 | −16 |
| R3-OH (A) | −16 | −105 | 4 | −20 | ||
| R4-OH (A) | 7 | −82 | 25 | −18 | ||
| R6-OH (B) | −3 | −93 | 30 | −34 | ||
| R7-OH (B) | −15 | −104 | 20 | −35 | ||
| NH | 45 | −45 | 67 | −23 | ||
| O2.− | R2-OH (A) | 63 | 382 | −318 | 14 | 49 |
| R3-OH (A) | 37 | −344 | −7 | 45 | ||
| R4-OH (A) | 60 | −322 | 13 | 47 | ||
| R6-OH (B) | 50 | −332 | 19 | 31 | ||
| R7-OH (B) | 39 | −343 | 9 | 30 | ||
| NH | 98 | −284 | 55 | 42 | ||
Growth inhibitory effects (IC50, μM) of Phes and commercial cytostatic drugs on MRC-5 and HCT-116 cell lines after 24 and 72 h exposure.
| 24 h | >500 | >500 | >500 | >500 | >500 | >500 | >500 | >500 | |
| 72 h | >500 | >500 | >500 | 306.5 | >500 | >500 | >500 | >500 | |
| 24 h | >500 | 249.4 | >500 | >500 | >500 | >500 | >500 | >500 | |
| 72 h | >500 | 139.1 | >500 | 66.6 | >500 | >500 | 315.9 | >500 | |
| 24 h | >500 | >500 | >500 | 37.9 | >500 | >500 | >500 | >500 | |
| 72 h | >500 | 232.7 | >500 | 87.3 | >500 | >500 | >500 | >500 | |
| 24 h | >500 | 26.9 | >500 | 80.5 | >500 | >500 | >500 | >500 | |
| 72 h | >500 | 70.5 | >500 | 26.2 | >500 | >500 | 61.2 | 208 | |
| 24 h | >500 | >500 | >500 | >500 | >500 | >500 | >500 | >500 | |
| 72 h | >500 | >500 | >500 | 213.2 | >500 | >500 | 439.7 | >500 | |
| 24 h | >500 | >500 | >500 | >500 | >500 | >500 | >500 | >500 | |
| 72 h | >500 | 101.3 | >500 | 94.1 | >500 | >500 | 129.8 | 106.9 | |
| 24 h | >500 | >500 | >500 | >500 | >500 | >500 | >500 | >500 | |
| 72 h | >500 | 290 | >500 | 127.6 | >500 | >500 | 306.6 | >500 | |
| 24 h | >500 | 249.7 | >500 | >500 | >500 | >500 | 193.5 | >500 | |
| 72 h | >500 | 91.4 | >500 | 202.1 | >500 | >500 | >500 | >500 | |
| 24 h | 175.46 | 104.44 | 91.99 | 179.64 | >500 | 84.33 | 76.35 | >500 | |
| 72 h | 59.24 | 52.15 | 31.88 | 457.52 | 45.76 | 40.0 | 78.6 | 50.55 | |
| 24 h | 247.2 | 62.6 | 71.75 | 89.91 | >500 | 86.92 | 99.9 | >500 | |
| 72 h | 63.53 | 32.35 | 38.45 | >500 | 65.23 | 43.6 | 77.34 | 58.76 | |
| 24 h | >500 | >500 | |||||||
| 72 h | 179.76 | 35.19 | |||||||
| 24 h | >500 | >500 | |||||||
| 72 h | >500 | 100.88 | |||||||
Selectivity index of modification b and commercial cytostatic drugs after 24 and 72 h exposure.
| SI | 3b | leucovorin | irinotecan | ||||
|---|---|---|---|---|---|---|---|
| 24 h | >2.01 | >18.59 | 1.00 | >2.00 | 1.67 | 1.00 | 1.00 |
| 72 h | >3.59 | 3.30 | >4.94 | 3.17 | 1.61 | <0.36 | 0.35 |
Selectivity index. SI values of 5a–h group of hydrazones and commercial cytostatic drugs after 24 and 72 h exposure.
| SI | leucovorin | irinotecan | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 24 h | 0.71 | 1.67 | 1.28 | 2.00 | 1.00 | 0.97 | 0.76 | 1.00 | 1.00 | 1.00 |
| 72 h | 0.93 | 1.61 | 0.83 | <0.92 | 0.70 | 0.92 | 1.02 | 0.86 | <0.36 | 0.35 |